Open original FDA record ↗Recall record
- FDA identifier
- Z-0308-04
- Company in FDA record
- Heartport Inc
- FDA classification date
- Jan 9, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Damaged hemostasis valves that prevent or present difficulty when inserting catheters.
Source facts
- Action
- Recall was first initiated on/about 10/2/03 by phone domestically from the Director of Marketing to the firm''s Sales Force (no phone script available). Following the initial phone call, formal recall letters were sent out on 10/6/03 to: Director of CV Suite; Director of the OR; and Director of Material Management of each hospital.
- Initiated
- 2003-10-02
- Root cause
- Other
- Terminated
- 2005-10-19
- Distribution
- Products were distributed domestically to 45 customers in CA, DC, FL, GA, IN, MD, MI, MN, MO, NC, NJ, NY, OH, PA, SC, TN, TX, VA, WA, and WI. The products were also distributed internationally to Israel, Austria, France, Germany, Italy, Belgium, Slovenia, Spain and UK. There was one US government consignment, Veterans Affairs Palo Alto, located at Health Care System, 3801 Miranda Ave. WHSE 50, Palo Alto, CA.
- Recall number
- Z-0308-04
- Recall status
- Terminated
- CDRH record ID
- 30223
- FDA classified
- 2004-01-09
- Recall event number
- 27410